Abstract:Tumorigenesis is always concomitant with microenvironmental alterations. The tumor microenvironment is a heterogeneous and complex milieu, which exerts a variety of stresses on tumor cells for proliferation, survival, or death. Recently, accumulated evidence revealed that metabolic and oxidative stresses both play significant roles in tumor development and progression that converge on a common autophagic pathway. Tumor cells display increased metabolic autonomy, and the hallmark is the exploitation of aerobic glycolysis (termed Warburg effect), which increased glucose consumption and decreased oxidative phosphorylation to support growth and proliferation. This characteristic renders cancer cells more aggressive; they devour tremendous amounts of nutrients from microenvironment to result in an ever-growing appetite for new tumor vessel formation and the release of more "waste," including key determinants of cell fate like lactate and reactive oxygen species (ROS). The intracellular ROS level of cancer cells can also be modulated by a variety of stimuli in the tumor microenvironment, such as pro-growth and pro-inflammatory factors. The intracellular redox state serves as a double-edged sword in tumor development and progression: ROS overproduction results in cytotoxic effects and might lead to apoptotic cell death, whereas certain level of ROS can act as a second-messenger for regulation of such cellular processes as cell survival, proliferation, and metastasis. The molecular mechanisms for cancer cell responses to metabolic and oxidative stresses are complex and are likely to involve multiple molecules or signaling pathways. In addition, the expression and modification of these proteins after metabolic or oxidative stress challenge are diverse in different cancer cells and endow them with different functions. Therefore, MS-based high-throughput platforms, such as proteomics, are indispensable in the global analysis of cancer cell responses to metabolic and oxidative stress. Herein, we highlight recent advances in the understanding of the metabolic and oxidative stresses associated with tumor progression with proteomics-based systems biology approaches.

ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway

Redox Signaling: Potential Arbitrator of Autophagy and Apoptosis in Therapeutic Response

Mitochondrial Redox Signaling And Tumor Progression

Redox Regulation of Autophagy in Cancer: Mechanism, Prevention and Therapy

Targeting Metabolic-Redox Circuits for Cancer Therapy

Unravelling the relationship between macroautophagy and mitochondrial ROS in cancer therapy

The Critical Role of AMPK in Driving Akt Activation under Stress, Tumorigenesis and Drug Resistance

Recent Advances in Cellular Signaling Interplay between Redox Metabolism and Autophagy Modulation in Cancer: An Overview of Molecular Mechanisms and Therapeutic Interventions

Redox Dysregulation in the Tumor Microenvironment Contributes to Cancer Metastasis.

Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression

Redox regulation of cancer metastasis: molecular signaling and therapeutic opportunities.

The double-edged roles of ROS in cancer prevention and therapy

Reactive Oxygen Species, Metabolic Plasticity, and Drug Resistance in Cancer

Proteomics analysis of tumor microenvironment: Implications of metabolic and oxidative stresses in tumorigenesis

AMPK and Cancer.

Reactive Oxygen Species and NRF2 Signaling, Friends or Foes in Cancer?

Reactive Oxygen Species Regulation of Autophagy in Cancer: Implications for Cancer Treatment.

ROS signalling in the biology of cancer

Uncovering crosstalk between AMPK and the ATF4-Integrated Stress Response

Oxidative Stress in Cancer Cell Metabolism

Moonlighting Metabolic Enzymes in Cancer: New Perspectives on the Redox Code